Amneal Pharmaceuticals Inc. (AMRX)
NASDAQ · Healthcare
Amneal Pharmaceuticals Inc. Revenue 2016–2025
Amneal Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Amneal Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 722.5 M, a 3.90% increase year-over-year.
- Amneal Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 2.9 B, a 9.07% increase year-over-year.
- Amneal Pharmaceuticals Inc. annual revenue for 2025 was 3.0 B, a 8.05% increase from 2024.
- Amneal Pharmaceuticals Inc. annual revenue for 2024 was 2.8 B, a 16.73% increase from 2023.
- Amneal Pharmaceuticals Inc. annual revenue for 2023 was 2.4 B, a 8.20% increase from 2022.
- Amneal Pharmaceuticals Inc. annual revenue for 2022 was 2.2 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amneal Pharmaceuticals Inc. Market Cap — FAQ
Amneal Pharmaceuticals Inc. (AMRX) market cap over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMRX's market cap history?
The chart and table above show Amneal Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.